In melanoma cells, constitutive SMAD signaling occurs in response to autocrine TGF-β secretion [35], and experimental blockade of TGF-β signaling by SMAD7 overexpression dramatically reduces their tumorigenic and metastatic potential [36,37]. Here, SMAD7 is linked to melanoma.